2+ hour, 12+ min ago  (1039+ words) For International Women's Day, Dr Amanda Hemmerich, Global Director of Digital Pathology & Innovation at IQVIA Laboratories, describes how digital pathology is being applied in early drug development and what it takes to build credibility in a multidisciplinary technical field. To…...

2+ day, 20+ hour ago  (401+ words) Insilico Medicine and Liquid AI have partnered to develop a lightweight artificial intelligence foundation model designed to support multiple stages of drug discovery. A new partnership between artificial intelligence developers Insilico Medicine and Liquid AI has produced a lightweight scientific…...

3+ day, 1+ hour ago  (560+ words) Flare Therapeutics has selected Simplicis Ledger" as its primary compound and inventory management platform, marking a strategic move toward a more resilient and automated approach to drug discovery. Life sciences software provider Simplicis has announced that Flare Therapeutics will implement…...

3+ day, 3+ hour ago  (736+ words) Most labs want to use AI, but few have the digital foundations to support it. Cenevo's leaders explain why progress is slow and what laboratories must fix before AI can deliver real value. To understand why AI adoption remains slow…...

5+ day, 1+ hour ago  (1446+ words) Drug discovery has no shortage of powerful technologies, but the challenge now is making them work together. At SLAS Boston 2026, researchers and technology developers revealed how laboratories are connecting the entire experimental pipeline. This was evident throughout SLAS Boston. Companies…...

1+ week, 6+ day ago  (509+ words) In drug discovery, great science alone is not enough because commercial viability ultimately decides which programmes survive and attract partners. This Q&A explores how integrating Business Development and Licensing (BD&L) from the earliest stages can guide R&D strategy,…...

2+ week, 2+ day ago  (1449+ words) The UK has set out a strategy to replace animal testing, but delivering change will depend as much on regulation as on technology. Dr Emma Grange, Director of Science and Regulatory Affairs at Cruelty Free International, examines what the policy…...

2+ week, 6+ day ago  (810+ words) As AI drug discovery enters 2026, the industry faces a pivotal year of clinical tests, regulatory clarity, and market consolidation. Here, Dr Raminderpal Singh examines where AI is delivering measurable gains in early discovery, where hype outpaces reality and why Phase…...

3+ week, 2+ day ago  (1579+ words) Artificial intelligence is increasingly used to analyse large, multimodal Alzheimer's datasets and inform target discovery and trial design. A new JPAD special issue highlights how these methods are moving from experimentation towards practical application in drug discovery. AI is now…...

3+ week, 3+ day ago  (632+ words) A new platform from Promega enables scientists to measure compound binding directly in living cells, helping to translate biochemical hits into more reliable drug discovery decisions. Promega Corporation has introduced a new platform designed to help drug discovery scientists study…...